483 Epic Pharma Feb 2002

483 Epic Pharma Feb 2002

Rochelle Kimmel FDA, Michael Levin FDA$119.00 - Available Now

FDA investigators audited the Epic Pharma - Laurelton, NY, United States facility and issued inspectional observations (via FDA 483) on 21 Feb 2002.

Product details

  • Category: Human Drugs
  • Inspection end: 21 Feb 2002
  • Location: Laurelton, United States
  • FEI: 2431929
Add To Cart